Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors.

Next Previous
Trial Profile

An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Linifanib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions

Most Recent Events

  • 02 Aug 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
  • 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 03 May 2012 Planned End Date changed from 1 Feb 2013 to 1 Jun 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top